Kinetics of penetration influence the apparent potency of vanilloids on TRPV1

被引:29
|
作者
Lazar, J
Braun, DC
Tóth, A
Wang, Y
Pearce, LV
Pavlyukovets, VA
Blumberg, PM
Garfield, SH
Wincovitch, S
Choi, HK
Lee, J
机构
[1] NCI, Lab Cellular Carcinogenesis & Tumor Promot, NIH, Bethesda, MD 20892 USA
[2] NCI, Expt Carcinogenesis Lab, NIH, Bethesda, MD 20892 USA
[3] Gallaudet Univ, Dept Biol, Washington, DC 20002 USA
[4] Seoul Natl Univ, Coll Pharm, Pharmaceut Sci Res Inst, Seoul, South Korea
关键词
D O I
10.1124/mol.105.019158
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
Evidence that the ligand binding site of TRPV1 lies on the inner face of the plasma membrane and that much of the TRPV1 itself is localized to internal membranes suggests that the rate of ligand entry into the cell may be an important determinant of the kinetics of ligand action. In this study, we synthesized a BODIPY TR-labeled fluorescent capsaicin analog (CHK-884) so that we could directly measure ligand entry. We report that CHK-884 penetrated only slowly into Chinese hamster ovary (CHO) cells expressing rat TRPV1, with a t(1/2) of 30 +/- 4 min, and localized in the endoplasmic reticulum and Golgi. Although CHK-884 was only weakly potent for TRPV1 binding (K-i = 6400 +/- 230 nM), it was appreciably more potent when assayed by intracellular calcium imaging and was 3.2-fold more potent with a 1-h incubation time ( 37 nM) than with a 5-min incubation time. Olvanil, a highly lipophilic vanilloid, yielded an EC50 of 4.3 nM upon intracellular calcium imaging with an incubation time of 1 h, compared with an EC50 value of 29.5 nM for calcium imaging assayed at 5 min. Likewise, the antagonist 5-iodoresiniferatoxin (5-iodo-RTX) displayed a K-i of 4.2 pM if incubated with CHO-TRPV1 cells for 2 h before addition of capsaicin compared with 1.5 nM if added simultaneously. We conclude that some vanilloids may have slow kinetics of uptake; this slow uptake may affect assessment of structure activity relations and may represent a significant factor for vanilloid drug design.
引用
收藏
页码:1166 / 1173
页数:8
相关论文
共 50 条
  • [31] TRPV1 in migraine pathophysiology
    Meents, Jannis E.
    Neeb, Lars
    Reuter, Uwe
    TRENDS IN MOLECULAR MEDICINE, 2010, 16 (04) : 153 - 159
  • [32] Biological Functions of TRPV1
    Liu Xia-Yang
    Li Zhuang
    Zhou Xin-Yue
    Guo Xiao-Hong
    PROGRESS IN BIOCHEMISTRY AND BIOPHYSICS, 2023, 50 (03) : 437 - 447
  • [33] TRPV1 and Synaptic Transmission
    Matta, Jose A.
    Ahern, Gerard P.
    CURRENT PHARMACEUTICAL BIOTECHNOLOGY, 2011, 12 (01) : 95 - 101
  • [34] The TRPV1 receptor and nociception
    Immke, David C.
    Gavva, Narender R.
    SEMINARS IN CELL & DEVELOPMENTAL BIOLOGY, 2006, 17 (05) : 582 - 591
  • [35] Phosphoinositide Regulation of TRPV1
    Lukacs, Viktor
    Thyagarajan, Baskaran
    Rohacs, Tibor
    BIOPHYSICAL JOURNAL, 2012, 102 (03) : 342A - 342A
  • [36] TRPV1 in microvascular regulation
    Miriel, V
    Rivers, R
    FASEB JOURNAL, 2006, 20 (04): : A271 - A271
  • [37] Structure and function of TRPV1
    Makoto Tominaga
    Tomoko Tominaga
    Pflügers Archiv, 2005, 451 : 143 - 150
  • [38] TRPV1 and corneal Pain
    Senning, Eric
    Gordon, Sharona
    INVESTIGATIVE OPHTHALMOLOGY & VISUAL SCIENCE, 2013, 54 (15)
  • [39] Structure and function of TRPV1
    Tominaga, M
    Tominaga, T
    PFLUGERS ARCHIV-EUROPEAN JOURNAL OF PHYSIOLOGY, 2005, 451 (01): : 143 - 150
  • [40] TRPV1 SUMOylation suppresses itch by inhibiting TRPV1 interaction with H1 receptors
    Gao, Yingwei
    Ma, Ruining
    Weng, Weiji
    Zhang, Heng
    Wang, Yingping
    Guo, Rongjun
    Gu, Xiaokun
    Yang, Yang
    Yang, Fan
    Zhou, Aiwu
    Cheng, Jinke
    Chen, Zhe-Yu
    Zhu, Michael X.
    Li, Yong
    CELL REPORTS, 2022, 39 (11):